| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $17.5M | -22.3% |
| SG&A Expense | $11.7M | -3.7% |
| Operating Income | -$29.2M | +15.8% |
| Interest Expense | $1.4M | -10.4% |
| Income Tax | $0 | — |
| Net Income | -$29.5M | +17.4% |
| EPS (Basic) | -$1.91 | +38.2% |
| EPS (Diluted) | -$1.91 | +38.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.2M | +25.6% |
| Current Assets | $40.4M | +22.5% |
| Total Assets | $51.6M | +12.0% |
| Current Liabilities | $9.4M | +29.3% |
| Long-term Debt | $10.5M | +1.0% |
| Total Liabilities | $24.8M | -11.2% |
| Stockholders' Equity | $26.8M | +47.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.4M | +12.0% |
| Capital Expenditures | $170K | -69.8% |
| Investing Cash Flow | -$170K | +69.8% |
| Financing Cash Flow | $35.6M | +212.2% |
| Free Cash Flow | -$27.5M | +13.0% |